Preconditioning, anesthetics, and perioperative medication.

Area of Science:

• Cardiovascular Physiology
• Cell Signaling
• Mitochondrial Function

Background:

• Endogenous signal transduction pathways, activated by stimuli like ischemic preconditioning, protect the heart from injury.
• Key signaling molecules include adenosine-regulated potassium channels, cyclooxygenase-2, kinases, and nitric oxide synthase.
• These pathways converge on mitochondria to mediate cardioprotection.

Purpose of the Study:

• To review the role of endogenous signal transduction pathways in myocardial protection.
• To examine how disease states and perioperative medications impact these protective pathways.
• To provide recommendations for perioperative anesthetic and medication use.

Main Methods:

• Review of experimental evidence from animal and clinical studies.
• Analysis of the roles of specific ion channels and proteins in cardioprotective signaling.
• Evaluation of the effects of disease and medications on signal transduction.

Main Results:

• Activation of specific signaling pathways is crucial for myocardial protection against ischemia-reperfusion injury.
• Impairment of ion channels and signaling proteins by disease or medications (e.g., sulfonylureas, COX-2 antagonists) can compromise cardioprotection.
• Mitochondria are a common convergence point for cardioprotective signaling.

Conclusions:

• Understanding signal transduction is vital for preserving myocardial function during surgery.
• Careful consideration of perioperative medications and patient disease states is necessary to optimize cardioprotection.
• Further research into modulating these pathways could enhance clinical strategies for heart protection.